News Archive

2019

• March 18 – Dr Joshua Dunaief MD joins Mperia Therapeutics Inc. Clinical Advisory Board
• February 28 – Mperia Therapeutics Inc. appoints Dr Christian Weber to Clinical Advisory Board
• February 22 – Completion of a successful management buyout transaction at NuChem Therapeutics
• February 11 – AmorChem reinforces its innate immunity franchise with an investment in checkpoint control target SRSF3
• February 1 – 1st Edition of Sweet Pharma Day in the Greater Montreal, Canada

2018

• December 17 – AmorChem announces the creation of MyX Therapeutics Inc
• November 9 – Mperia hires a new CEO: Paul Chipperton
• November 5: VCCI selects AmorChem as venture capital fund
• November 1 – SemaThera hires a new CEO: Garth Cumberlidge
• April 12 – Fondaction invests in AmorChem
• March 21 – SemaThera closes a financing of 2M$US from AmorChem and Senju Pharmaceutical
• March 2 – AmorChem announces its new investment committee

2017

• December 8 – Winner of Knock Out 2017 – AmorChem
• December 6 – AmorChem closes its Funds II
• September 11 – SpecificiT closes a financing from Amorchem, AccelRx and Sanderling
• July 5 – Regulatory approval of Y3 implant for grand trocanter
• January 11 – AmorChem announces the creation of SemaThera Inc
• January 9 – AmorChem announces the creation of Corbin Therapeutics Inc

2016

• Winner of Knock Out 2016 – AmorChem
• AmorChem announces its 2016 Knock Out finalists
• AmorChem announces a transaction with Vertex
• AmorChem announces the creation of Mperia Therapeutics Inc

2015

• AmorChem 2015 Knock-Out Event winner FOR DISTRIBUTION
• AmorChem Cancer Immunotherary ENG FOR DISTRIBUTION
• AmorChem_Knock-Out_Event_Announcement_FOR_DISTRIBUTION
• Nanotechnology Press Release ENG FOR DISTRIBUTION

2014

• AmorChem CFTR ENG FOR RELEASE
• AmorChem frataxin ENG FOR RELEASE
• AmorChem- IGFTRAP ENG_090114_FINAL
• AmorChem SEMA3 ENG FOR RELEASE
• AmorChem_AML_2014_FOR DISTRIBUTION
• Communique de presse Ong CV_FRAN_FINAL
• Greater Trochanter press release ENG for release
• Knock out_invitation ENG Amorchem FRQS with logos
• Press release CD73 ENG for release
• Roche and AmorChem announce alliance to focus on myotonic dystrophy

2013

• AmorChem DM-1 press release FOR DISTRIBUTION
• AmorChem DUB press release FOR RELEASE
• AmorChem Knock-Out Event October 2 press release ENG
• AmorChem Knock-Out Event September 18 press release ENG FOR RELEASE
• AmorChem Poirier 17bHSD1 Press Release – FOR RELEASE
• AmorChem_KNOCK_OUT_Event_Invitation_ENG_for_distribution
• AmorChem-ABDH6 Press Release ENG FOR RELEASE
• AMORCHEM-CHATENET July 2013-Press Release ENG FINAL
• AmorChem-Coupal Press Release ENG FOR RELEASE
• AmorChem-DNMTI Press Release ENG FOR RELEASE
• AmorChem-Investment Committee Press Release ENG FOR RELEASE
• AmorChem-McBride Press Release ENG FOR RELEASE
• AmorChem-OXO-ETE Press Release ENG FOR RELEASE
• BELLUS – AmorChem Press Release – English FOR RELEASE
• Press Release – InflammatoRx – May 7 2013 FINAL
• SEIDAH may 2013-Communiqu� de presse ENG FOR RELEASE

2012

• April 3, 2012, AmorChem announces a deal with Dr. Nabil Seidah
• August 8, 2012 AmorChem announces a second deal with Dr. Nabil Seidah
• Dec 21 2012, AmorChem-Porous screw Press Release ENG_FOR RELEASE
• Nov 27, 2012, AmorChem-ONG Press Release ENG FINAL version

2011

• AmorChem_release_NuChem_and_Clement_December 2_2011_English_FINAL